Digital Health Global
FEBRUARY 5, 2024
To bolster this expansion, Vektor will increase clinical support and drive additional clinical studies to showcase the technology’s impact and inform future innovation as well as continue efforts to secure reimbursement. “At TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics.
Lloyd Price
FEBRUARY 24, 2019
As medical devices increasingly look to harness advances in artificial intelligence — enabling devices to guide patient therapy, for instance — regulatory processes will have to adapt here too. Another issue may be a future requirement to perform double-blind studies involving large patient cohorts for combination products.
Health Populi
JULY 2, 2018
The results of this Pew study tell us that consumers’ trust levels if various industry segments are low: especially for pharma, financial services, and marketers. What was intriguing about that research is that biotech was much more trusted than pharma, with biotech being seen as more innovative.
Expert insights. Personalized for you.
88 
Let's personalize your content